Amyloid beta binding partners in the brain tissue of older adults

The mechanism linking extracellular amyloid beta (Aβ) with intraneuronal tau tangles, pathological hallmarks of Alzheimer's disease (AD), is not understood; it was tested in the current study through Aβ binding partners.

• Publication year

  2025

• Venue

  Alzheimer's & Dementia

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/alz.70882PMID 41216806PMCID 12603791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density.

  2025cited by this paper
• Cortical Gray Matter Proteins Associated With Cerebral Amyloid Angiopathy in Community-Dwelling Older Adults: An Autopsy Study.

  2025cited by this paper
• Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics

  2025cited by this paper
• Guide to Decomposition of Causal Effects Into Mediation, Interaction, and Direct Effects

  2024cited by this paper
• Proteins linking APOE ɛ4 with Alzheimer's disease

  2024cited by this paper
• TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease

  2024cited by this paper
• 2024 Alzheimer's disease facts and figures

  2024cited by this paper
• Biomarker Changes during 20 Years Preceding Alzheimer's Disease.

  2024cited by this paper
• Patterning of the cell cortex by Rho GTPases

  2024cited by this paper
• Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis

  2024cited by this paper
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

  2024cited by this paper
• Structural variants linked to Alzheimer’s disease and other common age-related clinical and neuropathologic traits

  2024cited by this paper
• Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression

  2023cited by this paper
• Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

  2023cited by this paper
• High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies.

  2023cited by this paper
• Amyloid β Proteoforms Elucidated by Quantitative LC/MS in the 5xFAD Mouse Model of Alzheimer's Disease.

  2023cited by this paper
• Psychosocial experiences are associated with human brain mitochondrial biology

  2023cited by this paper
• Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment

  2023cited by this paper
• Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease

  2023cited by this paper
• Inferring protein expression changes from mRNA in Alzheimer’s dementia using deep neural networks

  2022cited by this paper
• cAMP‐induced decrease in cell‐surface laminin receptor and cellular prion protein attenuates amyloid‐β uptake and amyloid‐β‐induced neuronal cell death

  2022cited by this paper
• Amyloid Beta Is Internalized via Macropinocytosis, an HSPG- and Lipid Raft-Dependent and Rac1-Mediated Process

  2022influential reference
• Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates

  2022cited by this paper
• A screened PirB antagonist peptide antagonizes Aβ42-mediated inhibition of neurite outgrowth in vitro

  2021cited by this paper
• Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level

  2021cited by this paper
• Fluid Transport in the Brain.

  2021cited by this paper
• Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors.

  2021cited by this paper
• Tetrapeptide Ac-HAEE-NH2 Protects α4β2 nAChR from Inhibition by Aβ

  2020cited by this paper
• Synergy between amyloid-β and tau in Alzheimer’s disease

  2020cited by this paper
• Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain

  2020cited by this paper
• Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology

  2020cited by this paper
• A Quantitative Proteome Map of the Human Body.

  2020cited by this paper
• Cell biology and dynamics of Neuronal Na+/K+-ATPase in health and diseases.

  2020cited by this paper
• Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age

  2019cited by this paper
• Clustering of Tau fibrils impairs the synaptic composition of α3‐Na+/K+‐ATPase and AMPA receptors

  2019cited by this paper
• A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.

  2019cited by this paper
• Alzheimer’s disease frequency peaks in the tenth decade and is lower afterwards

  2019cited by this paper
• Cognition may link cortical IGFBP5 levels with motor function in older adults

  2019cited by this paper
• Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease

  2019cited by this paper
• Religious Orders Study and Rush Memory and Aging Project

  2018cited by this paper
• A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease

  2018cited by this paper
• The glymphatic pathway in neurological disorders.

  2018cited by this paper
• Sex differences in Alzheimer’s disease and common neuropathologies of aging

  2018influential reference
• Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease

  2018cited by this paper
• Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

  2018cited by this paper
• Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia

  2018cited by this paper
• Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels.

  2017cited by this paper
• Role of amyloid β protein receptors in mediating synaptic plasticity.

  2017cited by this paper
• Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

  2017cited by this paper
• Amyloid- Receptors: The Good, the Bad, and the Prion Protein*

  2016cited by this paper
• Tau co-organizes dynamic microtubule and actin networks

  2015cited by this paper
• Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly

  2015cited by this paper
• Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

  2014cited by this paper
• Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1

  2013cited by this paper
• National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

  2012cited by this paper
• The effect of multiple indicators on the power to detect inter-individual differences in change.

  2010cited by this paper
• Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

  2010influential reference
• In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.

  2004cited by this paper
• Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

  2004cited by this paper
• Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta.

  2003cited by this paper
• Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β

  2003cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• No citing papers are available for this paper.